DOI:
10.1055/s-00040811
Neurologie up2date
LinksClose Window
References
Henderson EJ, Lord SR, Brodie MA. et al.
Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Neurol 2016;
15: 249-258
DOI: 10.1016/S1474-4422(15)00389-0. (PMID: 26795874)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.